Literature DB >> 24715619

Licit and illicit drug use in cluster headache.

Amelie Govare1, Elizabeth Leroux.   

Abstract

Cluster headache patients seem to use more licit and illicit substances than the general population. The epidemiologic data supporting this is growing. We included the licit drugs in this review because their use seems to be driven by the same addiction mechanisms leading to illicit drug abuse. Some drugs may be used in an attempt to treat cluster headache, especially cocaine and hallucinogens. Drug exposure may also play a role in CH pathophysiology, as suggested by interesting data on tobacco use and second-hand smoke exposure. A common factor may contribute both to CH and drug use predisposition. Genetic factors may be at play, and the dopaminergic and orexinergic pathways could be targeted for future studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24715619     DOI: 10.1007/s11916-014-0413-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  82 in total

1.  Depression and anxiety in episodic and chronic cluster headache: a pilot study.

Authors:  Matthew S Robbins; Rachel Bronheim; Richard B Lipton; Brian M Grosberg; Sarah Vollbracht; Fred D Sheftell; Dawn C Buse
Journal:  Headache       Date:  2011-11-11       Impact factor: 5.887

2.  Response of cluster headache to psilocybin and LSD.

Authors:  R Andrew Sewell; John H Halpern; Harrison G Pope
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

3.  Cocaine-induced cluster-like headache.

Authors:  Gianfranco Cafforio; Nicola Morelli; Eugenia Rota; Riccardo Mario Piane; Monica Mazzoni
Journal:  Neurol Sci       Date:  2013-09-20       Impact factor: 3.307

4.  Illicit drugs and cluster headache: an inevitable discussion.

Authors:  Arne May
Journal:  Cephalalgia       Date:  2012-10       Impact factor: 6.292

5.  Reply to: 'illicit drugs and cluster headache: an inevitable discussion'.

Authors:  John H Halpern
Journal:  Cephalalgia       Date:  2013-03-08       Impact factor: 6.292

6.  Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  J Pharmacol Exp Ther       Date:  2006-10-03       Impact factor: 4.030

Review 7.  The endocannabinoid system and migraine.

Authors:  Rosaria Greco; Valeria Gasperi; Mauro Maccarrone; Cristina Tassorelli
Journal:  Exp Neurol       Date:  2010-03-29       Impact factor: 5.330

8.  Cluster headache and cocaine use.

Authors:  M Peñarrocha; J V Bagán; M A Peñarrocha; F J Silvestre
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-09

9.  Evaluation of beta-endorphin secretion in patients suffering from episodic cluster headache.

Authors:  R Franceschini; M Leandri; M V Gianelli; A Cataldi; E Bruno; E Rolandi; T Barreca
Journal:  Headache       Date:  1996 Nov-Dec       Impact factor: 5.887

Review 10.  Cluster headache, hypothalamus, and orexin.

Authors:  Philip R Holland; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2009-04
View more
  8 in total

1.  Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.

Authors:  Wm Jeptha Davenport
Journal:  CMAJ       Date:  2016-02-16       Impact factor: 8.262

Review 2.  Emerging relevance of circadian rhythms in headaches and neuropathic pain.

Authors:  Mark J Burish; Zheng Chen; Seung-Hee Yoo
Journal:  Acta Physiol (Oxf)       Date:  2018-07-25       Impact factor: 6.311

3.  Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.

Authors:  Martin Andersson; Mari Persson; Anette Kjellgren
Journal:  Harm Reduct J       Date:  2017-09-05

4.  Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data.

Authors:  Casey K Choong; Janet H Ford; Allen W Nyhuis; Shivang G Joshi; Rebecca L Robinson; Sheena K Aurora; James M Martinez
Journal:  Headache       Date:  2017-06-05       Impact factor: 5.887

Review 5.  Pharmacotherapy for Cluster Headache.

Authors:  Roemer B Brandt; Patty G G Doesborg; Joost Haan; Michel D Ferrari; Rolf Fronczek
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 6.  Lifestyle Modifications to Help Prevent Headache at a Developmental Age.

Authors:  Umberto Raucci; Alessandra Boni; Melania Evangelisti; Nicoletta Della Vecchia; Margherita Velardi; Fabiana Ursitti; Gianluca Terrin; Giovanni Di Nardo; Antonino Reale; Alberto Villani; Pasquale Parisi
Journal:  Front Neurol       Date:  2021-02-02       Impact factor: 4.003

Review 7.  Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.

Authors:  Sakari Santeri Rusanen; Suchetana De; Emmanuelle Andree Danielle Schindler; Ville Aleksi Artto; Markus Storvik
Journal:  Curr Pain Headache Rep       Date:  2022-06-27

8.  Increased use of illicit drugs in a Dutch cluster headache population.

Authors:  Ilse F de Coo; Willemijn C Naber; Leopoldine A Wilbrink; Joost Haan; Michel D Ferrari; Rolf Fronczek
Journal:  Cephalalgia       Date:  2018-10-05       Impact factor: 6.292

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.